Vascular endothelial growth factor receptor 3 (VEGFR-3) is required for car
diovascular development during embryogenesis. In adults, this receptor is e
xpressed in lymphatic endothelial cells, and mutant VEGFR3 alleles have bee
n implicated in human hereditary lymphedema. To better understand the basis
of its specific endothelial lineage-restricted expression, we have charact
erized the I VEGFR3 gene and its regulatory 5' flanking region. The human g
ene contains 31 exons, of which exons 30a and 30b are alternatively spliced
. The VEGFR3 proximal promoter is TATA-less and contains stretches of seque
nces homologous with the mouse Vegfr3 promoter region. In transfection expe
riments of cultured cells, the Vegfr3 promoter was shown to control endothe
lial cell-specific transcription of downstream reporter genes. This result
was further confirmed in vivo; in a subset of transgenic mouse embryos, a 1
.6 kb Vegfr3 promoter fragment directed weak lymphatic endothelial expressi
on of the LacZ marker gem. This suggests that endothelial cell-specific ele
ments occur in the proximal promoter, although further enhancer elements ar
e probably located elsewhere. The sequence, organization, and variation in
the VEGFR3 gene and its regulatory region provide important tools for the m
olecular genetic analysis of the lymphatic system and its disorders.